Last reviewed · How we verify

NCT06571760: SPIRARE I

Selective Pulmonary-artery Intervention to Reduce Acute Right-heart tEnsion-I

Completed NA Last updated 29 May 2025
What this trial tests

NA trial testing Vertex Pulmonary Embolectomy System in Pulmonary Embolism in 10 participants. Completed in 21 May 2025.

Timeline
10 September 2024
Primary endpoint
24 April 2025
21 May 2025

Quick facts

Lead sponsorNeptune Medical
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment10
Start date10 September 2024
Primary completion24 April 2025
Estimated completion21 May 2025
Sites2 locations across Austria, Poland

Drugs / interventions tested

Conditions studied

Sponsor

Neptune Medical

Who can join

Adults 18 to 79, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study study is a prospective, single-arm, multicenter study to evaluate the safety and effectiveness of the Vertex Pulmonary Embolectomy System in participants presenting with clinical signs and symptoms of pulmonary embolism.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Vertex Pulmonary Embolectomy System

Trials testing the same drug.

Other recruiting trials for Pulmonary Embolism

Currently open trials in the same condition.

Other Neptune Medical trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06571760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing